Tissue microarray data showed a broad range of distribution of GR expression in lung adenocarcinoma tumors with about half of all tumor sections showing at least a portion of the malignant cells with relatively high GR expression. This evidence concerns the gene NR3C1 and lung adenocarcinoma.